Literature DB >> 26663635

Utility of hematology analyzer and flow cytometry in timely and correct detection of circulating plasma cells: Report of three cases.

Evdoxia Gounari1, Vasiliki Tsavdaridou1, Triantafyllia Koletsa2, Androula Nikolaidou3, Georgia Kaiafa4, Maria Papaioannou5, Ioannis Kostopoulos2, Lemonia Skoura1.   

Abstract

BACKGROUND: Circulating neoplastic plasma cells (PCs) are a common feature between classical plasma cell myeloma (PCM) and its aggressive variant, plasma cell leukemia (PCL), with their early suspicion and detection being of clinical importance for prognostic and diagnostic purposes.
METHODS: Morphological and flow cytometric enumeration and characterization of peripheral blood (PB) neoplastic PCs were performed in 3 PCM patients after complete blood count (CBC) evaluation.
RESULTS: Early suspicion of circulating PCs by initial CBC scatter plots and monocytosis led to morphological enumeration of PCs, with low level of concordance between morphologists. Flow cytometric PB analysis permitted accurate quantification and characterization of circulating clonal PCs.
CONCLUSIONS: CBC findings can prompt early suspicion of circulating PCs in PCM patients leading to early and accurate flow cytometric analysis of clonal PCs in addition to morphological PB evaluation. The suggested combined approach proved to be most important in the PCL case with discordant morphological evaluations and marginal PC numbers according to current criteria.
© 2016 International Clinical Cytometry Society. © 2016 International Clinical Cytometry Society.

Entities:  

Keywords:  flow cytometry; hematology analyzer; plasma cell leukemia; plasma cell myeloma

Mesh:

Year:  2016        PMID: 26663635     DOI: 10.1002/cyto.b.21350

Source DB:  PubMed          Journal:  Cytometry B Clin Cytom        ISSN: 1552-4949            Impact factor:   3.058


  1 in total

1.  Necessity of flow cytometry assessment of circulating plasma cells and its connection with clinical characteristics of primary and secondary plasma cell leukaemia.

Authors:  Renata Bezdekova; Tomas Jelinek; Romana Kralova; Martin Stork; Petra Polackova; Pavla Vsianska; Lucie Brozova; Jiri Jarkovsky; Martina Almasi; Ivanna Boichuk; Zdenka Knechtova; Miroslav Penka; Ludek Pour; Sabina Sevcikova; Roman Hajek; Lucie Rihova
Journal:  Br J Haematol       Date:  2021-09-09       Impact factor: 8.615

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.